Macrophages and HIV-1

Current Opinion in HIV and AIDS

Volumn 6, Issue 5, 2011, Pages 385-390

  Cobos Jiménez, Viviana ^a   Booiman, Thijs ^a   Hamann, Jörg ^a   Kootstra, Neeltje A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HIV; HIV 1 associated neurocognitive disorder; immune evasion; innate immunity; macrophage; microRNA

Indexed keywords

MICRORNA; VIRUS RNA;

ANTIVIRAL THERAPY; APOPTOSIS; AUTOPHAGY; CELL FUNCTION; CELL SURVIVAL; COMBINATION CHEMOTHERAPY; CYTOKINE PRODUCTION; GENE EXPRESSION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; PERSISTENT INFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROGENY; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS ASSEMBLY; VIRUS DNA CELL DNA INTERACTION; VIRUS ENTRY; VIRUS LATENCY; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOTHERAPY; MACROPHAGES;

EID: 80051801311     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3283497203     Document Type: Review

References (72)

1. Rich EA, Chen IS, Zack JA, et al. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992; 89:176-183.
2. Sonza S, Maerz A, Deacon N, et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 1996; 70:3863-3869. (Pubitemid 26157366)
3. Cassol E, Cassetta L, Rizzi C, et al. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol 2009; 182:6237-6246.
4. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008; 319:921-926. (Pubitemid 351263756)
5. Konig R, Zhou Y, Elleder D, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008; 135:49-60.
6. Yeung ML, Houzet L, Yedavalli VS, et al. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009; 284:19463-19473.
7. Zhou H, Xu M, Huang Q, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008; 4:495-504.
8. Bol SM, van Remmerden Y, Sietzema JG, et al. Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 2009; 390:205-211.
9. Bol SM, Moerland PD, Limou S, et al. Genomewide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS One 2011; 6:e17190.
10. Ballana E, Pauls E, Clotet B, et al. beta5 integrin is the major contributor to the alphaVintegrin-mediated blockade of HIV-1 replication. J Immunol 2011; 186:464-470.
11. Carter GC, Bernstone L, Baskaran D, et al. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 2011; 409:234-250.
12. Bergamaschi A, David A, Le RE, et al. The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J Virol 2009; 83:12253-12265.
13. Li G, Dziuba N, Friedrich B, et al. A postentry role for CD63 in early HIV-1 replication. Virology 2011; 412:315-324.
14. Bukong TN, Hall WW, Jacque JM. Lentivirus-associated MAPK/ERK2 phosphorylates EMD and regulates infectivity. J Gen Virol 2010; 91 (Pt 9):2381-2392.
15. Souza TM, Rodrigues DQ, Passaes CP, et al. The nerve growth factor reduces APOBEC3G synthesis and enhances HIV-1 transcription and replication in human primary macrophages. Blood 2011; 117:2944-2952.
16. Rom S, Rom I, Passiatore G, et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 2010; 24:2292-2300.
17. Bauby H, Lopez-Verges S, Hoeffel G, et al. TIP47 is required for the production of infectious HIV-1 particles from primary macrophages. Traffic 2010; 11:455-467.
18. Rai T, Mosoian A, Resh MD. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity. J Virol 2010; 84:9783-9792.
19. Dong C, Kwas C, Wu L. Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 2009; 83:3518-3527.
20. Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 2009; 5:e1000263.
21. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 2007; 13:1241-1247. (Pubitemid 47530631)
22. Wang X, Ye L, Hou W, et al. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 2009; 113:671-674.
23. Bennasser Y, Le SY, Benkirane M, et al. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005; 22:607-619. (Pubitemid 40719196)
24. Klase Z, Kale P, Winograd R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 2007; 8:63.
25. Klase Z, Winograd R, Davis J, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 2009; 6:18.
26. Lamers SL, Fogel GB, McGrath MS. HIV-miR-H1 evolvability during HIV pathogenesis. Biosystems 2010; 101:88-96.
27. Omoto S, Ito M, Tsutsumi Y, et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology 2004; 1:44.
28. Ouellet DL, Plante I, Landry P, et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 2008; 36:2353-2365. (Pubitemid 351567008)
29. Coley W, Van DR, Carpio L, et al. Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem 2010; 285:31930-31943.
30. Bennasser Y, Jeang KT. HIV-1 Tat interaction with Dicer: requirement for RNA. Retrovirology 2006; 3:95.
31. Sanghvi VR, Steel LF. A re-examination of global suppression of RNA interference by HIV-1. PLoS One 2011; 6:e17246.
32. Zhou Y, Wang X, Liu M, et al. A critical function of toll-like receptor-3 in the induction of antihuman immunodeficiency virus activities in macrophages. Immunology 2010; 131:40-49.
33. Yagi Y, Watanabe E, Watari E, et al. Inhibition of DC-SIGN-mediated transmission of human immunodeficiency virus type 1 by Toll-like receptor 3. signalling in breast milk macrophages. Immunology 2010; 130: 597-607.
34. Mosoian A, Teixeira A, Burns CS, et al. Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc Natl Acad Sci USA 2010; 107:10178-10183.
35. Ahmed N, Hayashi T, Hasegawa A, et al. Suppression of human immunodeficiency virus type 1 replication in macrophages by commensal bacteria preferentially stimulating Toll-like receptor 4. J Gen Virol 2010; 91:2804-2813.
36. Suh HS, Zhao ML, Choi N, et al. TLR3 and TLR4 are innate antiviral immune receptors in human microglia: role of IRF3 in modulating antiviral and inflammatory response in the CNS. Virology 2009; 392:246-259.
37. Brichacek B, Vanpouille C, Kiselyeva Y, et al. Contrasting roles for TLR ligands in HIV-1 pathogenesis. PLoS One 2010; 5.
38. Schlaepfer E, Speck RF. TLR8 activates HIV from latently infected cells of myeloid-monocytic origin directly via the MAPK pathway and from latently infected CD4+ T cells indirectly via TNF-{alpha}. J Immunol 2011; 186: 4314-4324.
39. Goujon C, Malim MH. Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol 2010; 84:9254-9266.
40. Cheney KM, McKnight A. Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication. PLoS One 2010; 5:e13521.
41. Tsang J, Chain BM, Miller RF, et al. HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS 2009; 23:2255-2263.
42. Yan N, Regalado-Magdos AD, Stiggelbout B, et al. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010; 11:1005-1013.
43. Solis M, Nakhaei P, Jalalirad M, et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011; 85:1224-1236.
44. Swingler S, Mann A, Jacque J, et al. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999; 5: 997-1003. (Pubitemid 29439569)
45. Dai L, Stevenson M. A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages. J Virol 2010; 84:8327-8331.
46. Rodriguez-Garcia M, Porichis F, de Jong OG, et al. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J Leukoc Biol 2010; 89:507-515.
47. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10. production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 2010; 16:452-459.
48. Mazzolini J, Herit F, Bouchet J, et al. Inhibition of phagocytosis in HIV-1-infected macrophages relies on Nef-dependent alteration of focal delivery of recycling compartments. Blood 2010; 115:4226-4236.
49. Espert L, Varbanov M, Robert-Hebmann V, et al. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 2009; 4:e5787.
50. Kyei GB, Dinkins C, Davis AS, et al. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 2009; 186:255-268.
51. Van Grol J, Subauste C, Andrade RM, et al. HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 2010; 5:e11733.
52. Li JC, Au KY, Fang JW, et al. HIV-1 trans-activator protein dysregulates IFNgamma signaling and contributes to the suppression of autophagy induction. AIDS 2011; 25:15-25.
53. Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011; 62:141-155.
54. Churchill MJ, Wesselingh SL, Cowley D, et al. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009; 66:253-258.
55. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985; 313:1493-1497. (Pubitemid 16182477)
56. Koenig S, Gendelman HE, Orenstein JM, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089-1093. (Pubitemid 16032241)
57. Eggert D, Dash PK, Gorantla S, et al. Neuroprotective activities of CEP-1347 in models of neuroAIDS. J Immunol 2010; 184:746-756.
58. Eggert D, Dash PK, Serradji N, et al. Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders. J Neuroimmunol 2009; 213:47-59.
59. Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytesmacrophages in HIV-1 infection. Retrovirology 2010; 7:30.
60. Eugenin EA, Osiecki K, Lopez L, et al. CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS. J Neurosci 2006; 26: 1098-1106. (Pubitemid 43237041)
61. El-Hage N, Wu G, Ambati J, et al. CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol 2006; 178: 9-16. (Pubitemid 44307341)
62. El-Hage N, Wu G, Wang J, et al. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 2006; 53:132-146.
63. Buckner CM, Calderon TM, Willams DW, et al. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the bloodbrain barrier and infection by HIV: implications for NeuroAIDS. Cell Immunol 2011; 267:109-123.
64. Muratori C, Mangino G, Affabris E, et al. Astrocytes contacting HIV-1-infected macrophages increase the release of CCL2 in response to the HIV-1-dependent enhancement of membrane-associated TNFalpha in macrophages. Glia 2010; 58:1893-1904.
65. Lamers SL, Gray RR, Salemi M, et al. HIV-1 phylogenetic analysis shows HIV-1. transits through the meninges to brain and peripheral tissues. Infect Genet Evol 2011; 11:31-37.
66. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005; 5:69-81. (Pubitemid 40070332)
67. Medders KE, Sejbuk NE, Maung R, et al. Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J Immunol 2010; 185:4883-4895.
68. Wu DT, Woodman SE, Weiss JM, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 2000; 6 (Suppl 1):S82-S85. (Pubitemid 30342781)
69. Akhtar LN, Qin H, Muldowney MT, et al. Suppressor of cytokine signaling 3 inhibits antiviral IFN-beta signaling to enhance HIV-1 replication in macrophages. J Immunol 2010; 185:2393-2404.
70. Campbell GR, Watkins JD, Loret EP, et al. Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C Tat proteins. AIDS Res Hum Retroviruses 2010; 27:647-654.
71. Constantino AA, Huang Y, Zhang H, et al. HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity. Neurotox Res 2011 [Epub ahead of print].
72. Schouten J, Cinque P, Gisslen M, et al. HIV-1 infection and cognitive impairment in the cART-era: a review. AIDS 2010; 25:561-575.